FOXO TECHNOLOGIES INC. Files 8-K with Material Agreements

TL;DR

FOXO filed an 8-K detailing material agreements and equity sales.

AI Summary

On June 7, 2024, FOXO TECHNOLOGIES INC. entered into a material definitive agreement. The company also disclosed unregistered sales of equity securities and provided a Regulation FD disclosure. This 8-K filing includes financial statements and exhibits related to these events.

Why It Matters

This filing indicates significant corporate actions and potential changes in the company's financial structure or operational agreements, which could impact investors.

Risk Assessment

Risk Level: medium — Material definitive agreements and unregistered equity sales can introduce financial and regulatory risks.

Key Players & Entities

• FOXO TECHNOLOGIES INC. (company) — Registrant
• Delwinds Insurance Acquisition Corp. (company) — Former Company Name
• June 7, 2024 (date) — Date of Report
• June 13, 2024 (date) — Filing Date

FAQ

Key Financial Figures

• $0.0001 — tered Class A Common Stock, par value $0.0001 FOXO NYSE American Indicate by ch
• $500,000 — ommon Stock) for total consideration of $500,000 (the " Myrtle Purchase Price "), which
• $500,000 b — k of the Company determined by dividing $500,000 by the volume weighted average price (the
• $20,000,000 — ferred Stock for total consideration of $20,000,000 (the " RCHI Purchase Price "). If the E
• $5,000,000 — he signing of the RCHI SEA in excess of $5,000,000 (cumulative) then RHI will receive an e

Filing Documents

• ea0207835-8k_foxotech.htm (8-K) — 52KB
• ea020783501ex99-1_foxotech.htm (EX-99.1) — 164KB
• ea020783501ex99-2_foxotech.htm (EX-99.2) — 175KB
• ea020783501ex99-3_foxotech.htm (EX-99.3) — 20KB
• ex99-3_001.jpg (GRAPHIC) — 16KB
• 0001213900-24-052489.txt ( ) — 694KB
• foxow-20240607.xsd (EX-101.SCH) — 3KB
• foxow-20240607_lab.xml (EX-101.LAB) — 33KB
• foxow-20240607_pre.xml (EX-101.PRE) — 22KB
• ea0207835-8k_foxotech_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement. Myrtle Recovery Centers Acquisition On June 10, 2024, FOXO Technologies Inc., a Delaware corporation (the " Company "), entered into the Stock Exchange Agreement (the " Myrtle SEA ") with Myrtle Recovery Centers, Inc., a Tennessee corporation (" Myrtle "), and Rennova Health, Inc., a Delaware corporation (" RHI "). Pursuant to the Myrtle SEA, upon closing, RHI will exchange with the Company 100 shares of Common Stock of Myrtle (which represents 98.4% of the issued and outstanding shares of Myrtle Common Stock) for total consideration of $500,000 (the " Myrtle Purchase Price "), which payment will be made by the issuance of a number of shares of Class A Common Stock of the Company determined by dividing $500,000 by the volume weighted average price (the " VWAP ") on the day immediately prior to the closing date (the " Price ") but in no event will the number of shares be more than 19.99% of the number of outstanding shares of the Company's Class A Common Stock on the trading day prior to the closing date. If the number of FOXO Shares to be issued to RHI multiplied by the Price is less than $500,000, the Company will pay the deficit in cash within 12 months from the closing date. If the earnings before interest, taxes, depreciation and amortization (" EBITDA ") indicated in the audited financial statements of Myrtle varies by more than 10% from the Myrtle Financial Statements (as defined in the Myrtle SEA), the Myrtle Purchase Price will automatically increase or decrease on a dollar for dollar basis and, if increased, the difference will be paid in additional shares of Class A Common Stock of the Company or cash or, if decreased, the difference will result in either cancellation of Class A Common Stock of the Company or return of cash paid. Closing of the Myrtle SEA is subject to deliverables referenced in the Myrtle SEA. A copy of the Myrtle SEA is attached hereto as Exhibit 99.1 and is hereby incorporated

02 Unregistered Sales of Equity Securities

Item 3.02 Unregistered Sales of Equity Securities. In the Current Report on Form 8-K filed with by the Company with the SEC on May 9, 2024, the Company reported 10,160,261 shares of Class A Common Stock were issued and outstanding. On June 3, 2024, the Company issued 506,997 shares of the Company's Class A Common Stock to Smithline Family Trust II (" Smithline ") pursuant to the Exchange Agreement dated May 28, 2024 (the " Agreement "). On June 7, 2024, the Company issued 532,296 shares of the Company's Class A Common Stock to Smithline pursuant to the Agreement. The securities issued above were made in reliance upon the exemption from securities registration afforded by Section 3(a)(9) of the Securities Act of 1933, as amended (the " Securities Act "). There were no sales commissions paid pursuant to these transactions.

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On June 14, 2024, the Company will issue a press release announcing it has entered into the Myrtle SEA and the RCHI SEA. A copy of the press release is attached hereto as Exhibit 99.3 and is incorporated herein by reference. The information under this Item 7.01, including Exhibit 99.3 hereto, is being furnished herewith and shall not be deemed "filed" for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall such information be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibit hereto, is material or that the dissemination of such information is required by Regulation FD. Cautionary This Current Report on Form 8-K contains "forward-looking statements." Any statements contained in this Current Report on Form 8-K that do not describe historical facts may constitute forward-looking statements. In some cases, you can identify forward-looking "anticipates," "believes," "estimates," "predicts," "potential" or "continue" or the negative of these terms or other comparable terminology and include statements regarding the NYSE American Notice and whether the Company will regain compliance with the NYSE American's continued listing standards. These forward-looking statements are based on information currently available to the Company's management as well as estimates and assumptions made by its management and are subject to risks and uncertainties that may cause actual results, performance or developments to d

forward-looking statements after such date

forward-looking statements after such date.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Share Exchange Agreement dated June 10, 2024 by, between, and among by and among FOXO Technologies Inc., Myrtle Recovery Centers, Inc., and Rennova Health, Inc. 99.2 * Share Exchange Agreement dated June 10, 2024 by and among FOXO Technologies Inc., Rennova Community Health, Inc., and Rennova Health, Inc. 99.3 Press Release dated June 14, 2024 104 Cover Page Interactive Data File (embedded within Inline XBRL document) * The exhibits have been omitted and are available upon request of the SEC. 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. FOXO Technologies Inc. Date: June 13, 2024 By: /s/ Mark White Name: Mark White Title: Interim Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR